Supporting life science start-ups and projects since 2013.
Supporting life science start-ups and projects since 2013.
About
KSI Ventures is a private venture company with strong expertise in life science with focus on Russian market.
We are an early stage seed investor, accelerator and business partner for commercialization and market launch of innovative projects.
We work with international academia, biotech and medtech companies and Russian local players to perform win-win strategy for all.
We are an early stage seed investor, accelerator and business partner for commercialization and market launch of innovative projects.
We work with international academia, biotech and medtech companies and Russian local players to perform win-win strategy for all.
Partner
Founder, Partner
Igor Krylov
Oleg Korzinov
Leaders
Graduated from the Military Medical Academy named after S.M. Kirov in St. Petersburg with a degree in General Medicine with the qualification of a military doctor.
1995 to 2003 - leading positions in Eli Lilly Vostok S.A., Aventis.
2004 - 2014 - General Director, Pharmstandard holding #1 Russian Pharma Company
2014 - 2015 - Director for Government Relations and Strategic Development of AstraZeneca in the Russia and Eurasia region.
2015 - First Vice President - Operations Director of CJSC MEDSI Group of Companies
2017 - 2020 - Managing Director, Marathon Group.
1995 to 2003 - leading positions in Eli Lilly Vostok S.A., Aventis.
2004 - 2014 - General Director, Pharmstandard holding #1 Russian Pharma Company
2014 - 2015 - Director for Government Relations and Strategic Development of AstraZeneca in the Russia and Eurasia region.
2015 - First Vice President - Operations Director of CJSC MEDSI Group of Companies
2017 - 2020 - Managing Director, Marathon Group.
Graduated from the Moscow Institute of Physics and Technology in 2008 and the HULT International Business School in London in 2019.
2005 to 2010 - ChemRar Group of Companies.
2017-2020 - Vice President of Torrey Pines Investment for Corporate Development in Emerging Markets.
2011 - 2017 - Executive Director of the Severny Biopharmcluster, a non-profit partnership created to develop medical and pharmaceutical projects in the Moscow region.
2013 to present - General Director of KSI Ventures.
2005 to 2010 - ChemRar Group of Companies.
2017-2020 - Vice President of Torrey Pines Investment for Corporate Development in Emerging Markets.
2011 - 2017 - Executive Director of the Severny Biopharmcluster, a non-profit partnership created to develop medical and pharmaceutical projects in the Moscow region.
2013 to present - General Director of KSI Ventures.
Greek letter KSI (XI) originates from Semitic letter Samekh.
Samekh or Simketh is the fifteenth letter of many Semitic abjads, representing /s/.One of the theory that Samekh comes from Djed symbol.
The Djed is one of the more ancient and commonly found symbols in ancient Egyptian religion. It is a pillar-like symbol in Egyptian hieroglyphs associated with the creator god Ptah and Osiris and representing stability as well as fertility and productivity.
Samekh or Simketh is the fifteenth letter of many Semitic abjads, representing /s/.One of the theory that Samekh comes from Djed symbol.
The Djed is one of the more ancient and commonly found symbols in ancient Egyptian religion. It is a pillar-like symbol in Egyptian hieroglyphs associated with the creator god Ptah and Osiris and representing stability as well as fertility and productivity.
Story of the Name
